Institutional investors hold a majority ownership of GILD through the 80.38% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2015, these large investors purchased a net $32.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FINANCIAL MANAGEMENT, ... Bought 2.5 Million shares of Gilead Sciences
EATON VANCE MANAGEMENT Bought 2.2 Million shares of Gilead Sciences
ROBECO INVESTMENT MANAGEMENT, IN... Bought 2.0 Million shares of Gilead Sciences